Cited by 896Alzheimer's disease research and treatmentsRedox biology and oxidative stressDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Oxidative stress in Alzheimer’s disease

Open access

Smith, Mark A., Rottkamp, Catherine A., Nunomura, Akihiko, Raina, Arun K., Perry, George·2000·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

DOI 10.1016/s0925-4439(00)00040-5

Open this paper in CoChat — free account Open PDF

Abstract

Oxidative balance is emerging as an important issue in understanding the pathogenesis of Alzheimer's disease. Examination of Alzheimer's disease brain has demonstrated a great deal of oxidative damage, associated with both hallmark pathologies (senile plaques and neurofibrillary tangles) as well as in normal appearing pyramidal neurons. While this suggests that oxidative stress is a proximal event in Alzheimer's disease pathogenesis, the mechanisms by which redox balance is altered in the disease remains elusive. Determining which of the proposed sources of free radicals, which include mitochondrial dysfunction, amyloid-beta-mediated processes, transition metal accumulation and genetic factors like apolipoprotein E and presenilins, is responsible for redox imbalance will lead to a better understanding of Alzheimer's disease pathogenesis and novel therapeutic approaches.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0925-4439(00)00040-5

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

RETRACTED: Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease
Davis, R. E., Miller, S., Herrnstadt, C., Ghosh, S. S., Fahy, E., Shinobu, L. A., Galasko, D., Thal, L. J., Beal, M. F., Howell, N., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4526 · Cited by 341
Retracted
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Role of Oxidative Stress in Development of Complications in Diabetes
Baynes, J. (1991) · Diabetes · doi:10.2337/diab.40.4.405 · Cited by 3,791
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., et al. (1996) · Nature · doi:10.1038/382685a0 · Cited by 2,012
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
Mattson, M. P., Cheng, B., Davis, D. G., Bryant, K., Lieberburg, I. M., & Rydel, R. E. (1992) · Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,633
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,365
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239

Show all 52 references

Research works printed but not linked: 3

Good, 1996, Am. J. Pathol., 149, 21
Montine, 1996, Am. J. Pathol., 148, 89
Cras, 1990, Am. J. Pathol., 137, 241

Sorted by citations

Items 101–200 of 896

Glycation—a sweet tempter for neuronal death
Kikuchi, S. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00273-4 · Cited by 169
The Role of Oxidative Stress in the Pathophysiology of Cerebrovascular Lesions in Alzheimer's Disease
Aliev, G., Smith, M. A., Seyidova, D., Neal, M. L., Lamb, B. T., Nunomura, A., Gasimov, E. K., Vinters, H. V., Perry, G. L., LaManna, J. C., et al. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00419.x · Cited by 169
Solution 1H NMR investigation of Zn2+ and Cd2+ binding to amyloid-beta peptide (Aβ) of Alzheimer's disease
Syme, C. D., & Viles, J. H. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.09.012 · Cited by 167
Hydrogen Peroxide Promotes Aβ Production through JNK-dependent Activation of γ-Secretase
Shen, C., Chen, Y., Liu, H., Zhang, K., Zhang, T., Lin, A., & Jing, N. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800013200 · Cited by 170
Functional vitamin B 12 deficiency and Alzheimer disease
McCaddon, A., Regland, B., Hudson, P. R., & Davies, G. K. (2002) · Neurology · doi:10.1212/wnl.58.9.1395 · Cited by 166
Regulation of Bcl‐2 family proteins, neurotrophic factors, and APP processing in the neurorescue activity of propargylamine
Bar‐Am, O., Weinreb, O., Amit, T., & Youdim, M. B. H. (2005) · The FASEB Journal · doi:10.1096/fj.05-3794fje · Cited by 165
Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury
Conte, V., Uryu, K., Fujimoto, S., Yao, Y., Rokach, J., Longhi, L., Trojanowski, J. Q., Lee, V. M., McIntosh, T. K., & Praticò, D. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02560.x · Cited by 164
Free Radicals in Human Health and Disease
Yadav, U. C. S., & Rani, V. (2014) · Springer eBooks · doi:10.1007/978-81-322-2035-0 · Cited by 163
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases
Cruz-Haces, M., TANG, J. C. Y., Acosta, G., Fernandez, J., & Shi, R. (2017) · Translational Neurodegeneration · doi:10.1186/s40035-017-0088-2 · Cited by 166
Mitochondrial ATP-synthase in the entorhinal cortex is a target of oxidative stress at stages I/II of Alzheimer’s disease pathology
Terni, B., Boada, J., Portero‐Otin, M., Pamplona, R., & Ferrer, I. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00266.x · Cited by 159
Propargylamine-derived multitarget-directed ligands: fighting Alzheimer’s disease with monoamine oxidase inhibitors
Bolea, I., Gella, A., & Unzeta, M. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0948-y · Cited by 158
Strawberry and Its Anthocyanins Reduce Oxidative Stress-Induced Apoptosis in PC12 Cells
Heo, H. J., & Lee, C. Y. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf048616l · Cited by 156
Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease
Pasinetti, G. M., & Eberstein, J. A. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05454.x · Cited by 160
Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric Aβ
Zhao, W.-Q., Lacor, P. N., Chen, H., Lambert, M. P., Quon, M. J., Krafft, G. A., & Klein, W. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.011015 · Cited by 154
The Role of Damage-Associated Molecular Patterns (DAMPs) in Human Diseases : Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine
Land, W. G. (2015) · Sultan Qaboos University medical journal · doi:10.18295/2075-0528.1676 · Cited by 157
Inflammation-Dependent Cerebral Deposition of Serum Amyloid A Protein in a Mouse Model of Amyloidosis
Guo, J.-T., Yu, J., Grass, D., de Beer, F. C., & Kindy, M. S. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05900.2002 · Cited by 156
Lipid peroxidation in neurodegeneration: new insights into Alzheimerʼs disease
Arlt, S., Beisiegel†, U., & Kontush, A. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200206000-00009 · Cited by 151
Neuroprotective adaptations in hibernation: therapeutic implications for ischemia-reperfusion, traumatic brain injury and neurodegenerative diseases
Drew, K. L., Rice, M. E., Kuhn, T. B., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00628-1 · Cited by 150
Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E‐related disorders in humans
Moghadasian, M. H., McManus, B. M., Nguyen, L. B., Shefer, S., Nadji, M., Godin, D. V., Green, T. J., Hill, J. S., Yang, Y., Scudamore, C. H., et al. (2001) · The FASEB Journal · doi:10.1096/fj.01-0463com · Cited by 150
Oxidative Imbalance in Alzheimer's Disease
Zhu, X., Lee, H., Casadesús, G., Ávila, J., Drew, K. L., Perry, G. L., & Smith, M. A. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:205 · Cited by 146
Technological Competence Is a Pre-condition for Effective Implementation of Virtual Reality Head Mounted Displays in Human Neuroscience: A Technological Review and Meta-Analysis
Kourtesis, P., Collina, S., Doumas, L. A. A., & MacPherson, S. E. (2019) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2019.00342 · Cited by 160
“…aims and/or populations and included patients with clinical conditions (e.g., Alzheimer’s disease, Parkinson’s disease, stroke, and movement disorders) which have high comorbidity with stress and anxiety (Factor et al., 1995; Smith et al., 2000; Jenner, 2003; Allen and Bayraktutan, 2009).”
Oxidative Stress, Neuroinflammation, and NADPH Oxidase: Implications in the Pathogenesis and Treatment of Alzheimer’s Disease
Ganguly, U., Kaur, U., Chakrabarti, S. S., Sharma, P., Agrawal, B. K., Saso, L., & Chakrabarti, S. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/7086512 · Cited by 157
Effect of the lipid peroxidation product acrolein on tau phosphorylation in neural cells
Gómez‐Ramos, A., Díaz‐Nido, J., Smith, M. A., Perry, G. L., & Ávila, J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10525 · Cited by 146
The Roles of Biomarkers of Oxidative Stress and Antioxidant in Alzheimer’s Disease: A Systematic Review
Chang, Y., Chang, W., Tsai, N., Huang, C., Kung, C., Su, Y., Lin, W.-C., Cheng, B., Su, C.-M., Chiang, Y.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/182303 · Cited by 145
Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Varesi, A., Carrara, A., Pires, V. G., Floris, V., Pierella, E., Savioli, G., Prasad, S., Esposito, C., Ricevuti, G., Chirumbolo, S., et al. (2022) · Cells · doi:10.3390/cells11081367 · Cited by 150
Effect of the Alzheimer amyloid fragment Aβ(25–35) on Akt/PKB kinase and survival of PC12 cells
Martı́n, D., Salinas, M., López‐Valdaliso, R., Serrano, E., Recuero, M., & Cuadrado, A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00472.x · Cited by 142
“Cell death induced by b-amyloid peptides has been correlated with the production of oxygen free radicals (Behl et al. 1994; Varadarajan et al. 2000) and may be prevented by antioxidant agents and oxygen-free radical scavengers (Sayre et al. 1999; Smith et al. 2000).”
Oxidative Stress Mediated Mitochondrial and Vascular Lesions as Markers in the Pathogenesis of Alzheimer Disease
Aliev, G., Priyadarshini, M., Reddy, V., Grieg, N. H., Kaminsky, Y., Cacabelos, R., Ashraf, G., Jabir, N. R., Kamal, M. A., Nikolenko, V. N., et al. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666131227161303 · Cited by 138
Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases
Migliore, L., Fontana, I., Colognato, R., Coppedè, F., Siciliano, G., & Murri, L. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.10.002 · Cited by 149
Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease
Nunomura, A., Chiba, S., Lippa, C. F., Cras, P. P., Kalaria, R. N., Takeda, A., Honda, K., Smith, M. A., & Perry, G. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.003 · Cited by 136
Selenium Intake, Mood and Other Aspects of Psychological Functioning
Benton, D. (2002) · Nutritional Neuroscience · doi:10.1080/1028415021000055925 · Cited by 134
Oxidative Stress in Alzheimer's Disease and Mild Cognitive Impairment with High Sensitivity and Specificity
López, N., Tormo, C., Blas, I. D., Llinares, I., & Alom, J. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121528 · Cited by 135
Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Alzheimer disease
Aliev, G., Smith, M. A., Obrenovich, M. E., de la Torre, J. C., & Perry, G. L. (2003) · Neurotoxicity Research · doi:10.1007/bf03033159 · Cited by 134
Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro
Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., & Yamada, M. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.035 · Cited by 134
Neuroprotective Properties of the Marine Carotenoid Astaxanthin and Omega-3 Fatty Acids, and Perspectives for the Natural Combination of Both in Krill Oil
Barros, M. P., Poppe, S. C., & Bondan, E. F. (2014) · Nutrients · doi:10.3390/nu6031293 · Cited by 134
Vitamin E in Neurodegenerative Disorders: Alzheimer's Disease
Kontush, A., & Schekatolina, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.025 · Cited by 132
Plasma lipidome is dysregulated in Alzheimer’s disease and is associated with disease risk genes
Liu, Y., Thalamuthu, A., Mather, K. A., Crawford, J. D., Ulanova, M., Wong, M. W. K., Pickford, R., Sachdev, P. S., & Braidy, N. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01362-2 · Cited by 140
Nicotine attenuates β‐amyloid peptide‐induced neurotoxicity, free radical and calcium accumulation in hippocampal neuronal cultures
Liu, Q., & Zhao, B. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705653 · Cited by 130
Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies
Martins, R. N., Villemagne, V., Sohrabi, H. R., Chatterjee, P., Shah, T. M., Verdile, G., Fraser, P., Taddei, K., Gupta, V. B., Rainey-Smith, S. R., et al. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171145 · Cited by 129
Oxidative Damage to RNA in Neurodegenerative Diseases
Nunomura, A., Honda, K., Takeda, A., Hirai, K., Zhu, X., Smith, M. A., & Perry, G. L. (2006) · BioMed Research International · doi:10.1155/jbb/2006/82323 · Cited by 133
Peripheral Mitochondrial Dysfunction in Alzheimer’s Disease: Focus on Lymphocytes
Leuner, K., Schulz, K. L., Schuett, T., Pantel, J., Prvulovic, D., Rhein, V. F., Savaskan, E., Czech, C., Eckert, A., & Müller, W. E. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8300-y · Cited by 127
Vitamin E and neurodegenerative diseases
Ricciarelli, R., Argellati, F., Pronzato, M. A., & Domenicotti, C. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.01.004 · Cited by 128
Targeting multiple pathogenic mechanisms with polyphenols for the treatment of Alzheimer's disease-experimental approach and therapeutic implications
Wang, J., Bi, W., Cheng, A., Freire, D., Vempati, P., Zhao, W., Gong, B., Janle, E. M., Chen, T., Ferruzzi, M. G., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00042 · Cited by 128
The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer's disease
Jayasena, T., Poljak, A., Smythe, G. A., Braidy, N., Münch, G. W., & Sachdev, P. S. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.06.003 · Cited by 122
Relationships between Mitochondrial Dysfunction and Neurotransmission Failure in Alzheimer’s Disease
Wong, K. Y., Roy, J., Fung, M., Heng, B. C., Zhang, C., & Lim, L. W. (2020) · Aging and Disease · doi:10.14336/ad.2019.1125 · Cited by 122
Tracking neuroinflammation in Alzheimer’s disease: the role of positron emission tomography imaging
Zimmer, E. R., Leuzy, A., Benedet, A. L., Breitner, J., Gauthier, S., & Rosa-Neto, P. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-120 · Cited by 121
Oxidative modification of lipoic acid by HNE in Alzheimer disease brain
Hardas, S. S., Sultana, R., Clark, A. M., Beckett, T. L., Szweda, L. I., Murphy, M. P., & Butterfield, D. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.01.002 · Cited by 120
A comprehensive review of multi-target directed ligands in the treatment of Alzheimer’s disease
Pathak, C., & Kabra, U. D. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.107152 · Cited by 128
Alzheimer's disease: diverse aspects of mitochondrial malfunctioning.
Santos, R. X., Correia, S. C., Wang, X., Perry, G. L., Smith, M. A., Moreira, P. I., & Zhu, X. (2010) · Europe PMC (PubMed Central) · Cited by 120
Phytochemical, nutraceutical and pharmacological attributes of a functional crop Moringa oleifera Lam: An overview
Singh, A. K., Rana, H. K., Tshabalala, T., Kumar, R., Gupta, A., Ndhlala, A. R., & Pandey, A. K. (2019) · South African Journal of Botany · doi:10.1016/j.sajb.2019.06.017 · Cited by 130
TRPM2 channel properties, functions and therapeutic potentials
Jiang, L., Yang, W., Zou, J., & Beech, D. J. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2010.510135 · Cited by 118
Nanoscale synchrotron X-ray speciation of iron and calcium compounds in amyloid plaque cores from Alzheimer's disease subjects
Everett, J. L., Collingwood, J. F., Tjhin, V. T., Brooks, J., Lermyte, F., Plascencia‐Villa, G., Hands-Portman, I., Dobson, J., Perry, G. L., & Telling, N. D. (2018) · Nanoscale · doi:10.1039/c7nr06794a · Cited by 122
The Cerebrocortical Areas in Normal Brain Aging and in Alzheimer's Disease: Noticeable Differences in the Lipid Peroxidation Level and in Antioxidant Defense
Karelson, E., Bogdanović, N., Garlind, A., Winblad, B. G., Zilmer, K., Kullisaar, T., Vihalemm, T., Kairane, C., & Zilmer, M. (2001) · Neurochemical Research · doi:10.1023/a:1010942929678 · Cited by 114
Neuronal failure in Alzheimer’s disease: a view through the oxidative stress looking-glass
Bonda, D., Wang, X., Lee, H., Smith, M. A., Perry, G. L., & Zhu, X. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1424-x · Cited by 114
Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimers Disease
Yamin, G., Ono, K., Inayathullah, M., & Teplow, D. B. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404137 · Cited by 111
Nucleic acid oxidation: an early feature of Alzheimer's disease
Bradley‐Whitman, M. A., Timmons, M. D., Beckett, T. L., Murphy, M. P., Lynn, B. C., & Lovell, M. A. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12444 · Cited by 112
“Altered cellular biomolecules and processes in early and late stages of AD include altered gene expression, increased protein oxidation, altered enzymatic activity, formation of nucleic acid adducts, and lipid peroxidation (reviewed in Markesbery 1997; Moreira et al. 2005; Smith et al. 2000).”
Background
Hippocampal memory enhancing activity of pine needle extract against scopolamine-induced amnesia in a mouse model
Lee, J.-S., Kim, H.-G., Lee, H.-W., Han, J.-M., Lee, S.-K., Kim, D.-W., Saravanakumar, A., & Son, C.-G. (2015) · Scientific Reports · doi:10.1038/srep09651 · Cited by 110
Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease
Naseer, M. I., Bibi, F., Al-Qahtani, M. H., Chaudhary, A., Azhar, E. I., Kamal, M. A., & Yasir, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660147 · Cited by 109
Cupric–amyloid β peptide complex stimulates oxidation of ascorbate and generation of hydroxyl radical
Dikalov, S., Vitek, M. P., & Mason, R. P. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.11.004 · Cited by 110
Multifunctional Neuroprotective Derivatives of Rasagiline as Anti-Alzheimer's Disease Drugs
Weinreb, O., Mandel, S. A., Bar‐Am, O., Yogev‐Falach, M., Avramovich‐Tirosh, Y., Amit, T., & Youdim, M. B. H. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.030 · Cited by 110
Reactive Oxygen Species, Redox Signaling and Neuroinflammation in Alzheimer's Disease: The NF-κB Connection
Kaur, U., Banerjee, P., Bir, A., Sinha, M. S., Biswas, A., & Chakrabarti, S. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150114160543 · Cited by 109
The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease
Wang, Z.-X., Tan, L., Liu, J., & Yu, J.-T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9143-0 · Cited by 110
Drug delivery strategies for Alzheimer's disease treatment
Stefano, A. D., Iannitelli, A., Laserra, S., & Sozio, P. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.561311 · Cited by 106
Evidence for Early Cytotoxic Aggregates in Transgenic Mice for Human Transthyretin Leu55Pro
Sousa, M. M., Fernandes, R., Palha, J. A., Taboada, A., Vieira, P., & Saraiva, M. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64469-0 · Cited by 108
Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease
Aliev, G., Palacios, H. H., Walrafen, B., Lipsitt, A. E., Obrenovich, M. E., & Morales, L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.015 · Cited by 102
Brain Endothelial Cells Synthesize Neurotoxic Thrombin in Alzheimer’s Disease
Yin, X., Wright, J., Wall, T., & Grammas, P. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090406 · Cited by 104
Neuronal and Vascular Oxidative Stress in Alzheimers Disease
Massaad, C. A. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376244 · Cited by 102
Rare Individual Amyloid-β Oligomers Act on Astrocytes to Initiate Neuronal Damage
Narayan, P. S., Holmström, K. M., Kim, D.-H., Whitcomb, D. J., Wilson, M. R., George‐Hyslop, P. S., Wood, N. W., Dobson, C. M., Cho, K., Abramov, A. Y., et al. (2014) · Biochemistry · doi:10.1021/bi401606f · Cited by 105
Altered Metabolism in Alzheimer Disease Brain: Role of Oxidative Stress
Rummel, N. G., & Butterfield, D. A. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0177 · Cited by 111
Mitochondrial Stress Signaling Promotes Cellular Adaptations
Barbour, J. A., & Turner, N. A. (2014) · International Journal of Cell Biology · doi:10.1155/2014/156020 · Cited by 108
The Proteasome and Oxidative Stress in Alzheimer's Disease
Bonet-Costa, V., Pomatto, L. C.-D., & Davies, K. J. A. (2016) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6802 · Cited by 99
Vitamin B12-B6-Folate Treatment Improves Blood-Brain Barrier Function in Patients with Hyperhomocysteinaemia and Mild Cognitive Impairment
Lehmann, M., Regland, B., Blennow, K., & Gottfries, C. G. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000071002 · Cited by 100
Effect of One-Year Vitamin C- and E-Supplementation on Cerebrospinal Fluid Oxidation Parameters and Clinical Course in Alzheimer’s Disease
Arlt, S., Müller‐Thomsen, T., Beisiegel†, U., & Kontush, A. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0860-8 · Cited by 100
Neurodegeneration and oxidative stress: prion disease results from loss of antioxidant defence.
Brown, D. R. (2005) · PubMed · Cited by 97
Natural Antioxidants for Neurodegenerative Diseases
Zhao, B. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:283 · Cited by 98
Gender and genetic background effects on brain metal levels in APP transgenic and normal mice: Implications for Alzheimer β-amyloid pathology
Maynard, C. J., Cappai, R., Volitakis, I., Cherny, R. A., Masters, C. L., Li, Q., & Bush, A. I. (2006) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2006.02.010 · Cited by 97
Impact of gender on upregulation of antioxidant defence mechanisms in Alzheimer?s disease brain
Schüssel, K., Leutner, S., Cairns, N. J., M�ller, W. E., & Eckert, A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0156-5 · Cited by 95
Elevated plasma levels of bilirubin in patients with neurotrauma reflect its pathophysiological role in free radical scavenging.
Dohi, K., Satoh, K., Ohtaki, H., Shioda, S., Miyake, Y., Shindo, M., & Aruga, T. (2005) · PubMed · Cited by 95
Biogenic metallic elements in the human brain?
Everett, J., Lermyte, F., Brooks, J., Tjendana-Tjhin, V., Plascencia-Villa, G., Hands-Portman, I., Donnelly, J. M., Billimoria, K., Perry, G., Zhu, X., et al. (2021) · Science Advances · doi:10.1126/sciadv.abf6707 · Cited by 94
Self-citation
Implantation of Neural Probes in the Brain Elicits Oxidative Stress
Ereifej, E. S., Rial, G. M., Hermann, J. K., Smith, C. S., Meade, S. M., Rayyan, J., Chen, K., He, F., & Capadona, J. R. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00009 · Cited by 94
The role of free radicals in canine counterpart of senile dementia of the Alzheimer type
Skoumalová, A. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00071-8 · Cited by 94
Transcranial near-infrared photobiomodulation attenuates memory impairment and hippocampal oxidative stress in sleep-deprived mice
Salehpour, F., Farajdokht, F., Erfani, M., Sadigh‐Eteghad, S., Shotorbani, S. S., Hamblin, M. R., Karimi, P., Rasta, S. H., & Mahmoudi, J. (2018) · Brain Research · doi:10.1016/j.brainres.2017.12.040 · Cited by 93
Effects of RAGE-Specific Inhibitor FPS-ZM1 on Amyloid-β Metabolism and AGEs-Induced Inflammation and Oxidative Stress in Rat Hippocampus
Yan, H., Shen, C., Yin, Q., Sun, M., Ma, Y., & Liu, X. (2016) · Neurochemical Research · doi:10.1007/s11064-015-1814-8 · Cited by 93
The Advances in Neurobiology
Ishwarya, M., & Narendhirakannan, R. T. (2016) · Advances in neurobiology · doi:10.1007/978-3-319-28383-8_15 · Cited by 91
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice
Aliev, G., Seyidova, D., Lamb, B. T., Obrenovich, M. E., Siedlak, S. L., Vinters, H. V., Friedland, R. P., Siedlak, S. L., Vinters, H. V., Friedland, R. P., et al. (2003) · Neurological Research · doi:10.1179/016164103101201977 · Cited by 91
Brain inflammation and oxidative stress in a transgenic mouse model of Alzheimer-like brain amyloidosis.
Yao, Y., Chinnici, C. M., Tang, H., Trojanowski, J. Q., Lee, V. M. ‐., & Praticò, D. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-21 · Cited by 91
Atherosclerotic Lesions and Mitochondria DNA Deletions in Brain Microvessels as a Central Target for the Development of Human AD and AD‐Like Pathology in Aged Transgenic Mice
Aliev, G., Seyidova, D., Neal, M. L., Shi, J., Lamb, B. T., Siedlak, S. L., Vinters, H. V., Head, E., Perry, G. L., LaManna, J. C., et al. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04798.x · Cited by 91
Experimental excitotoxicity provokes oxidative damage in mice brain and attenuation by extract of Asparagus racemosus
Parihar, M. S., & Hemnani, T. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0069-8 · Cited by 89
Alzheimer’s disease and total plasma aminothiols
McCaddon, A., Hudson, P. R., Hill, D., Barber, J., Lloyd, A., Davies, G. K., & Regland, B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01451-8 · Cited by 89
Myricetin ameliorates scopolamine-induced memory impairment in mice via inhibiting acetylcholinesterase and down-regulating brain iron
Wang, B., Zhong, Y., Gao, C., & Li, J. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.045 · Cited by 90
The Involvement of DNA-Damage and -Repair Defects in Neurological Dysfunction
Kulkarni, A., & Wilson, D. M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.009 · Cited by 89
Regulation of antioxidant enzymes gene expression in the yeast Saccharomyces cerevisiae during stationary phase
Cyrne, L., Martins, L. U., Fernandes, L., & Marinho, H. S. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01300-x · Cited by 87
Neural stem cell therapy for neurovascular injury in Alzheimer's disease
Boese, A. C., Hamblin, M. H., & Lee, J. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113112 · Cited by 89
Axonal Transport Defects in Alzheimer’s Disease
Wang, Z., Tan, L., & Yu, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8810-x · Cited by 92
Vitamin E protects neurons against oxidative cell death in vitro more effectively than 17-β estradiol and induces the activity of the transcription factor NF-κB
Behl, C. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070082 · Cited by 86
Tyrphostins Protect Neuronal Cells from Oxidative Stress
Sagara, Y., Ishige, K., Tsai, C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203895200 · Cited by 86
Expression of stress‐activated kinases c‐Jun N‐terminal kinase (SAPK/JNK‐P) and p38 kinase (p38‐P), and tau hyperphosphorylation in neurites surrounding βA plaques in APP Tg2576 mice
Puig, B., Gómez‐Isla, T., Ribé, E. M., Cuadrado‐Tejedor, M., Torrejón-Escribano, B., Dalfó, E., & Ferrer, I. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00569.x · Cited by 88
17β‐Estradiol activates ICI 182,780‐sensitive estrogen receptors and cyclic GMP‐dependent thioredoxin expression for neuroprotection
Lee, S. Y., Andoh, T., Murphy, D. L., & Chiueh, C. C. (2003) · The FASEB Journal · doi:10.1096/fj.02-0807fje · Cited by 86
Molecular evolution of aerobic energy metabolism in primates.
Grossman, L. I., Schmidt, T. R., Wildman, D. E., & Goodman, M. (2001) · Molecular Phylogenetics and Evolution · doi:10.1006/mpev.2000.0890 · Cited by 86
Characterization of the phenolic constituents in Mauritian endemic plants as determinants of their antioxidant activities in vitro
Neergheen, V. S., Soobrattee, M. A., Bahorun, T., & Aruoma, O. I. (2006) · Journal of Plant Physiology · doi:10.1016/j.jplph.2005.09.009 · Cited by 84
Application of nicotine enantiomers, derivatives and analogues in therapy of neurodegenerative disorders
Pogocki, D., Ruman, T., Danilczuk, M., Danilczuk, M., Celuch, M., & Wałajtys-Rode, E. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.038 · Cited by 84

Authors: Smith, M. A., Rottkamp, C. A., Nunomura, A., Raina, A. K., & Perry, G.
Affiliations: Case Western Reserve University (US)
Asahikawa Medical College Hospital (JP)
Corresponding author: Smith, Mark A.
ORCID: Smith, Mark A.
Rottkamp, Catherine A.
Nunomura, Akihiko
Perry, George
Venue: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher: Elsevier BV
Published: 2000-07
Volume: 1502
Issue: 1
Pages: 139-144
ISSN: 0925-4439 (ISSN-L)
DOI: 10.1016/s0925-4439(00)00040-5
OpenAlex: W1983789627
Cited by: 895
References: 52
Citations by year: 2026: 13 · 2025: 22 · 2024: 30 · 2023: 33 · 2022: 31 · 2021: 38 · 2020: 36 · 2019: 40 · 2018: 37 · 2017: 26 · 2016: 33 · 2015: 34 · 2014: 32 · 2013: 39 · 2012: 39
FWCI: 5.89
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 4765 d)
Locations: Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (publishedVersion)
PubMed (publishedVersion)
Biochimica et Biophysica Acta
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: oxidative stress, Alzheimer's disease, redox imbalance, free radicals, mitochondrial dysfunction, amyloid-beta, apolipoprotein E, presenilin, amyloid plaques, neurofibrillary tangles, pyramidal neurons, pathogenesis
MeSH terms: Alzheimer Disease, Antioxidants, Free Radicals, Humans, Neurons, Oxidation-Reduction, Peptide Fragments, Amyloid beta-Peptides, Neurofibrillary Tangles, Oxidative Stress, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oxidative stress in Alzheimer’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks